戻る
OSE Immunotherapeutics SA (ORPOF)価格
ORPOF 株価推移チャート
ORPOF 財務
OSE Immunotherapeutics SA
$11.6
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$11.6
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
収入
貸借対照表
現金の流れ
年次
四半期
ORPOF 収入
金額は百万米ドル単位。会計年度は2月から1月まで。
Follow-Up Questions
OSE Immunotherapeutics SAの主要な財務諸表は何ですか？
ORPOFの主要な財務比率は何ですか？
OSE Immunotherapeutics SAの収益はセグメントまたは地域別にどのように分けられていますか？
OSE Immunotherapeutics SAは収益を上げていますか？
OSE Immunotherapeutics SAに負債はありますか？
OSE Immunotherapeutics SAの発行済株式数は何株ですか？
主要データ
前終値
$11.6
始値
$11.6
当日レンジ
$11.6 - $11.6
52週レンジ
$11.6 - $11.6
取引高
748
平均取引高
0
1株当たり利益(TTM)
--
配当利回り
--
時価総額
$260.5M
ORPOFとは何ですか？
OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company is headquartered in Nantes, Pays De La Loire and currently employs 68 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.